Agree Realty Corporation ADC
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- -6.89%
- 1 year
- -7.96%
- Open
- 68.18
- Prev close
- 67.34
- Mkt cap
- 8.37B
- Vol
- 1.88M
- Avg vol
- 1.63M
- EPS
- 1.94
- P/E
- 34.57
- Div yield
- 4.81%
More statistics
- Low
- 66.82
- High
- 68.27
- Forward P/E
- 34.28
- Beta
- 0.42
- Short ratio
- 0.00
- Inst. own
- 112.30%
- Dividend
- 3.25
- Ex-div date
- Oct 29, 2026
- Earnings
- Feb 9, 2027
- 50-d avg
- 68.83
- 200-d avg
- 74.55
- 1y target
- 77.75
News
6 hours ago 247wallst.com
The 10-Year Treasury Yield Fell 33 Basis Points. Here Are 5 Net-Lease REITs to Watch
Long-term Treasury yields just pulled back sharply, and net-lease REITs stand to benefit more than almost any other corner of real estate.
1 day ago seekingalpha.com
If I Could Only Buy 3 REITs After The Sell-Off
REITs have sold off despite many maintaining strong fundamentals. Some blue-chip REITs now offer unusually attractive valuations and yields. Accelerating rent growth and lower rates could drive…
2 days ago 247wallst.com
Realty Income and Agree Realty Both Raised Guidance. Which Dividend Looks Stronger?
Two monthly dividend REITs both raised guidance this year, but one is charging into data centers while the other is pulling back on deals to guard its balance sheet.
2 days ago globenewswire.com
Akari Therapeutics to Highlight Novel RNA-Splicing ADC Payload Strategy at the 3rd Annual ADC Payload Summit
Presentation to explore the potential of RNA-splicing payloads to drive broad anti-tumor effects through direct cell killing along with immune activation
3 days ago prnewswire.com
ADC Therapeutics Announces ZYNLONTA® Updates in Japan
Licensing partner, Tanabe Pharma, filed for Japanese approval of ZYNLONTA (MT-2111) for relapsed or refractory DLBCL based on encouraging Japanese Phase 1/2 clinical results Tanabe Pharma entered…
3 days ago seekingalpha.com
Undercovered Dozen: Micron, i-80 Gold, Hercules Capital, And More
The Undercovered Dozen highlights 12 lesser-covered stocks with actionable investment theses and recent catalysts. Featured companies include i-80 Gold, Hercules Capital, and Aya Gold & Silver, each…
4 days ago 247wallst.com
How Large Does Your Portfolio Need to Be to Generate $10,300 a Month?
Generating over ten thousand dollars a month from a portfolio sounds like a retirement fantasy, but a specific blend of seven holdings makes the math surprisingly concrete. The tricky part is knowing…
-
5 days ago benzinga.com
Keybanc Maintains Overweight on Agree Realty, Lowers Price Target to $76
Keybanc analyst Upal Rana maintains Agree Realty (NYSE:ADC) with a Overweight and lowers the price target from $82 to $76.
6 days ago 247wallst.com
How Do You Tell a Yield Trap From a Real $6,400-a-Month Dividend Portfolio?
A 10% yield sounds like it solves the $6,400 monthly target with far less capital, but two of the three tests that expose a yield trap can disqualify a holding before you ever collect a check.
6 days ago seekingalpha.com
Agree Realty: Not Much Has Changed Except A Better Entry Point
Agree Realty offers a compelling entry point for long-term income investors at 14x AFFO and a near 5% yield. ADC's robust balance sheet, a credit rating of 'A,' and conservative payout ratio position…
1 week ago seekingalpha.com
REITs Rebound As Earnings Deliver
U.S. markets remained unsettled as cracks emerged in the AI investment boom, while another oil-price surge complicated the inflation outlook ahead of Wednesday's Fed decision. Treasury yields fell…
1 week ago 247wallst.com
How to Build $8,300 a Month in Dividend Income Without Owning a Single Bond
Generating nearly $100,000 a year in dividend income sounds impossible without a massive nest egg, but the capital you actually need swings wildly depending on where you invest and what risks you are…
1 week ago gurufocus.com
Sonesitatug vedotin reduced the risk of death by 42% in 2nd and later-line CLDN18.2-positive advanced gastric/GEJ cancers in CLARITY-Gastric01
Positive results from the CLARITY-Gastric01 global Phase III trial showed AstraZeneca's sonesitatug vedotin (Sone-Ve) demonstrated a statistically significant a
1 week ago globenewswire.com
ArriVent Announces Initial Phase 1 Data for CDH17-targeted ADC ARR-217 in Patients with Gastrointestinal Cancers at ESMO Congress 2026
NEWTOWN SQUARE, Pa., Oct. 25, 2026 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of…
1 week ago gurufocus.com
Bio-Thera Announces Promising Clinical Data for BAT8008 in Combination with BAT1308 in First-Line Non-Small Cell Lung Cancer at ESMO 2026
Bio-Thera Announces Promising Clinical Data for BAT8008 in Combination with BAT1308 in First-Line Non-Small Cell Lung Cancer at ESMO 2026PR NewswireGUANGZHOU, C
1 week ago gurufocus.com
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026
[url="]BeOne Medicines Ltd.[/url] (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated inve
1 week ago gurufocus.com
Lilly presents first clinical data in platinum-sensitive ovarian cancer for its investigational, next-generation, FRα-targeting ADC at ESMO 2026
Lilly presents first clinical data in platinum-sensitive ovarian cancer for its investigational, next-generation, FRα-targeting ADC at ESMO 2026PR NewswireINDI
1 week ago prnewswire.com
Lilly presents first clinical data in platinum-sensitive ovarian cancer for its investigational, next-generation, FRα-targeting ADC at ESMO 2026
Sofetabart mipitecan (Sofe-M) in combination with bevacizumab demonstrated a 79% confirmed objective response rate and 100% disease control rate, with similar activity observed across FR α expression…
1 week ago seekingalpha.com
Dividend Champion, Contender, And Challenger Highlights: Week October 25
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies that changed their dividends. Companies with upcoming ex-dividend dates.
1 week ago globenewswire.com
ArriVent to Present Initial Phase 1 Data for CDH17-targeted ADC ARR-217 in Patients with Gastrointestinal Cancers at the ESMO Congress 2026
NEWTOWN SQUARE, Pa., Oct. 23, 2026 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of…
-
1 week ago benzinga.com
Citigroup Maintains Neutral on Agree Realty, Lowers Price Target to $72
Citigroup analyst Nick Joseph maintains Agree Realty (NYSE:ADC) with a Neutral and lowers the price target from $82.5 to $72.
1 week ago gurufocus.com
Zai Lab Announces $250 Million Private Placement
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) an innovation-driven, global biopharma company, today announced that it has entered into a securities purchase agreem
-
1 week ago benzinga.com
BNP Paribas Maintains Neutral on Agree Realty, Lowers Price Target to $74
BNP Paribas analyst Nate Crossett maintains Agree Realty (NYSE:ADC) with a Neutral and lowers the price target from $84 to $74.
-
1 week ago benzinga.com
Stifel Maintains Buy on Agree Realty, Lowers Price Target to $76.5
Stifel analyst Simon Yarmak maintains Agree Realty (NYSE:ADC) with a Buy and lowers the price target from $81.5 to $76.5.
1 week ago benzinga.com
Agree Realty Q3 2026 Earnings Call Transcript
Agree Realty (NYSE:ADC) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you…
-
1 week ago benzinga.com
Baird Maintains Outperform on Agree Realty, Lowers Price Target to $76
Baird analyst RJ Milligan maintains Agree Realty (NYSE:ADC) with a Outperform and lowers the price target from $77 to $76.
-
1 week ago benzinga.com
Barclays Maintains Equal-Weight on Agree Realty, Lowers Price Target to $76
Barclays analyst Richard Hightower maintains Agree Realty (NYSE:ADC) with a Equal-Weight and lowers the price target from $85 to $76.
1 week ago benzinga.com
SpaceX, GE Aerospace On Deck Tuesday As Growth, Aerospace Demand Face Test
Space Exploration Technologies headlines Tuesday’s reports, with investors focused on whether Starlink growth and launch activity can justify the company’s scale. GE Aerospace, RTX, 3M, General…
-
1 week ago benzinga.com
Wells Fargo Maintains Overweight on Agree Realty, Lowers Price Target to $79
Wells Fargo analyst James Feldman maintains Agree Realty (NYSE:ADC) with a Overweight and lowers the price target from $83 to $79.
-
2 weeks ago benzinga.com
Agree Realty Raises Its Monthly Cash Dividend From $0.2670 To $0.271
Agree Realty Corporation (NYSE:ADC) (the "Company") today announced that its Board of Directors has authorized, and the Company has declared, a monthly cash dividend of $0.271 per common share,…
-
1 month ago benzinga.com
Truist Securities Assumes Agree Realty at Buy, Lowers Price Target of $75
Truist Securities analyst Linda Tsai assumes Agree Realty (NYSE:ADC) with a Buy rating and lowers Price Target of $75.
-
1 month ago benzinga.com
Evercore ISI Group Maintains Outperform on Agree Realty, Lowers Price Target to $85
Evercore ISI Group analyst James Kammert maintains Agree Realty (NYSE:ADC) with a Outperform and lowers the price target from $87 to $85.
-
1 month ago benzinga.com
Stifel Maintains Buy on Agree Realty, Lowers Price Target to $81.5
Stifel analyst Simon Yarmak maintains Agree Realty (NYSE:ADC) with a Buy and lowers the price target from $84 to $81.5.
-
1 month ago benzinga.com
Mizuho Maintains Neutral on Agree Realty, Lowers Price Target to $72
Mizuho analyst Haendel St. Juste maintains Agree Realty (NYSE:ADC) with a Neutral and lowers the price target from $80 to $72.
2 months ago benzinga.com
Agree Realty Vs. NNN REIT: Two 70% Payouts, 4x Unsettled Equity
The Print Agree Realty (NYSE:ADC) and NNN REIT (NYSE:NNN) entered the second half with annualized dividend payout ratios separated by less than half a percentage point. Agree’s $3.204 annualized…
-
3 months ago benzinga.com
Agree Realty Q2 FFO $1.14 Beats $1.13 Estimate, Sales $204.981M Beat $201.927M Estimate
Agree Realty (NYSE:ADC) reported quarterly earnings of $1.14 per share which beat the analyst consensus estimate of $1.13 by 0.88 percent. This is a 7.55 percent increase over earnings of $1.06 per…
-
3 months ago benzinga.com
Barclays Maintains Equal-Weight on Agree Realty, Raises Price Target to $85
Barclays analyst Richard Hightower maintains Agree Realty (NYSE:ADC) with a Equal-Weight and raises the price target from $84 to $85.
3 months ago benzinga.com
Recent Filing Shows That Rep. Josh Gottheimer Sold Over $7K Worth of Agree Realty Stock
A July filing shows that Representative Josh Gottheimer reported a sale in Agree Realty (NYSE:ADC), valued between $7,007 and $105,000. The transaction date is listed as June 1, 2026, with the report…
4 months ago benzinga.com
Agree Realty And Global Net Lease: One Yields 4%, One Yields 8%. The Balance Sheet Sets The Spread.
Agree Realty And Global Net Lease: One Yields 4%, One Yields 8%. The Balance Sheet Sets The Spread.
4 months ago benzinga.com
Alpha Buying: Insiders Are Buying Real Estate While Everyone Else Panics
Alpha Buying: Insiders Are Buying Real Estate While Everyone Else Panics
-
5 months ago benzinga.com
Barclays Maintains Equal-Weight on Agree Realty, Lowers Price Target to $84
Barclays analyst Richard Hightower maintains Agree Realty (NYSE:ADC) with a Equal-Weight and lowers the price target from $86 to $84.
5 months ago benzinga.com
Aramark To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts updated their ratings on top companies. For full list of changes, including upgrades/downgrades, see our analyst ratings page.
-
5 months ago benzinga.com
Mizuho Maintains Neutral on Agree Realty, Lowers Price Target to $80
Mizuho analyst Haendel St. Juste maintains Agree Realty (NYSE:ADC) with a Neutral and lowers the price target from $86 to $80.
-
6 months ago benzinga.com
RBC Capital Maintains Outperform on Agree Realty, Raises Price Target to $82
RBC Capital analyst Brad Heffern maintains Agree Realty (NYSE:ADC) with a Outperform and raises the price target from $81 to $82.
6 months ago benzinga.com
Agree Realty Q1 2026 Earnings Call: Complete Transcript
Agree Realty Q1 2026 Earnings Call: Complete Transcript
-
6 months ago benzinga.com
Baird Maintains Outperform on Agree Realty, Raises Price Target to $82
Baird analyst RJ Milligan maintains Agree Realty (NYSE:ADC) with a Outperform and raises the price target from $80 to $82.
-
6 months ago benzinga.com
Agree Realty Q1 FFO $1.14 Beats $1.10 Estimate, Sales $200.807M Beat $192.266M Estimate
Agree Realty (NYSE:ADC) reported quarterly earnings of $1.14 per share which beat the analyst consensus estimate of $1.10 by 2.7 percent. This is a 7.55 percent increase over earnings of $1.06 per…
-
6 months ago benzinga.com
Barclays Maintains Equal-Weight on Agree Realty, Raises Price Target to $86
Barclays analyst Richard Hightower maintains Agree Realty (NYSE:ADC) with a Equal-Weight and raises the price target from $81 to $86.
6 months ago benzinga.com
Wall Street's Most Accurate Analysts Spotlight On 3 Real Estate Stocks Delivering High-Dividend Yields
High-yielding stocks are often sought during market turbulence; Benzinga provides latest analyst ratings for dividend-paying stocks. In times of market uncertainty, investors turn to high-yielding…
6 months ago benzinga.com
Earnings Scheduled For April 21, 2026
Earnings Scheduled For April 21, 2026